J. Šterzl

2.1k total citations
82 papers, 1.6k citations indexed

About

J. Šterzl is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. Šterzl has authored 82 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 20 papers in Molecular Biology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. Šterzl's work include Immune Response and Inflammation (15 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Immune Cell Function and Interaction (12 papers). J. Šterzl is often cited by papers focused on Immune Response and Inflammation (15 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Immune Cell Function and Interaction (12 papers). J. Šterzl collaborates with scholars based in Czechia, Slovakia and United States. J. Šterzl's co-authors include I. Říha, Arthur M. Silverstein, L. Mandel, J. Kostka, J. Rejnek, Helena Tlaskalová‐Hogenová, J. Trávníček, Z. Trnka, Michael W. Russell and Susan Jackson and has published in prestigious journals such as Nature, Annals of the New York Academy of Sciences and Cellular and Molecular Life Sciences.

In The Last Decade

J. Šterzl

76 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Šterzl Czechia 21 773 330 232 196 184 82 1.6k
C Stiffel France 23 888 1.1× 365 1.1× 154 0.7× 221 1.1× 206 1.1× 120 2.1k
D Mouton France 23 1.0k 1.4× 533 1.6× 176 0.8× 272 1.4× 325 1.8× 129 2.4k
Michael McWilliams United States 15 759 1.0× 237 0.7× 135 0.6× 258 1.3× 148 0.8× 19 1.4k
Charles C. Muscoplat United States 23 605 0.8× 263 0.8× 204 0.9× 274 1.4× 100 0.5× 96 2.2k
J.P. Vaerman United States 17 439 0.6× 266 0.8× 81 0.3× 277 1.4× 84 0.5× 29 1.2k
Emanuel Suter United States 21 545 0.7× 240 0.7× 276 1.2× 73 0.4× 94 0.5× 47 1.3k
Warren R. Stinebring United States 17 482 0.6× 215 0.7× 142 0.6× 105 0.5× 91 0.5× 46 1.2k
Philip B. Carter United States 12 593 0.8× 286 0.9× 314 1.4× 204 1.0× 252 1.4× 20 1.5k
J. Goudswaard Netherlands 15 353 0.5× 314 1.0× 88 0.4× 181 0.9× 87 0.5× 54 1.1k
J R McGhee United States 26 1.2k 1.6× 403 1.2× 215 0.9× 155 0.8× 194 1.1× 59 2.1k

Countries citing papers authored by J. Šterzl

Since Specialization
Citations

This map shows the geographic impact of J. Šterzl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Šterzl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Šterzl more than expected).

Fields of papers citing papers by J. Šterzl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Šterzl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Šterzl. The network helps show where J. Šterzl may publish in the future.

Co-authorship network of co-authors of J. Šterzl

This figure shows the co-authorship network connecting the top 25 collaborators of J. Šterzl. A scholar is included among the top collaborators of J. Šterzl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Šterzl. J. Šterzl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Šterzl, I, Richard Hampl, J. Šterzl, J. Votruba, & L Stárka. (1999). 7β-OH-DHEA counteracts dexamethasone induced suppression of primary immune response in murine spleenocytes. The Journal of Steroid Biochemistry and Molecular Biology. 71(3-4). 133–137. 23 indexed citations
2.
Štëpánková, Renáta, et al.. (1995). Expression of MHC Class II Antigens and Enzymatic Activity in Enterocytes of Germ-Free and Conventional Rats: Dependence on Nutritional Factors During Suckling. Advances in experimental medicine and biology. 371A. 501–505. 3 indexed citations
3.
Šterzl, J., et al.. (1995). Induction and Recall of the Secondary Immune Response Entirely in Tissue Culture. Advances in experimental medicine and biology. 371A. 1–7. 3 indexed citations
4.
Tlaskalová‐Hogenová, Helena, et al.. (1994). Development of immune responses in early pig ontogeny. Veterinary Immunology and Immunopathology. 43(1-3). 135–142. 46 indexed citations
5.
Lodin, Z, et al.. (1988). Failure to detect the presence of pluripotential haemopoietic stem cells in the mouse brain. Journal of Neuroimmunology. 18(3). 217–222. 1 indexed citations
6.
Šterzl, J., et al.. (1987). The use of gnotobiological models for the studies of immune mechanisms. Food / Nahrung. 31(5-6). 599–608. 6 indexed citations
7.
Šterzl, J., F. Šantavý, Petr Sedmera, & J. Cudlín. (1982). Effect of colchicine derivatives on the antibody response inducedin vitro. Folia Microbiologica. 27(4). 256–266. 1 indexed citations
8.
Šterzl, J., et al.. (1981). The immuno inhibitory and immuno stimulatory effects of hydroxy anthra quinone and hydroxy naphtho quinone derivatives. Folia Microbiologica. 26(3). 169–175. 7 indexed citations
9.
Šterzl, J., et al.. (1981). A mathematical model of B lymphocyte differentiation: Control by antigen. Journal of Mathematical Biology. 13(1). 67–86. 10 indexed citations
10.
Šterzl, J., et al.. (1981). The immunoinhibitory and immunostimulatory effects of hydroxyanthra- and hydroxynaphthoquinone derivatives. Folia Microbiologica. 26(3). 169–175. 9 indexed citations
11.
Hájek, Petr, L. Mandel, & J. Šterzl. (1969). Different amounts of phi X 174 phage necesary for evoking a primary antibody response in newborn and adult animals.. PubMed. 13(2). 173–80. 1 indexed citations
12.
Šterzl, J., et al.. (1967). Effect of X-radiation and 6-MP on the secondary antibody response. Folia Microbiologica. 12(1). 21–30. 1 indexed citations
13.
Šterzl, J. & Arthur M. Silverstein. (1967). Developmental Aspects of Immunity. Advances in immunology. 6. 337–459. 228 indexed citations
14.
Šterzl, J., et al.. (1967). Influence of the amount of antigen and the interval on the secondary reaction. Folia Microbiologica. 12(1). 6–20. 9 indexed citations
15.
Šterzl, J., et al.. (1962). [The nature of properties of bactericidal serum against gram-negative micro-organisms].. PubMed. 101. 65–71. 18 indexed citations
16.
Šterzl, J., Miroslav Holub, & I Miler. (1961). Effect of endotoxin on antibody response and resistance to infection in Newborn animals. Folia Microbiologica. 6(5). 289–298. 12 indexed citations
17.
Šterzl, J., et al.. (1959). A Bactericidal substance not dependent on complement. Folia Microbiologica. 4(5). 280–285. 1 indexed citations
18.
Šterzl, J.. (1959). Maintenance of the ability of cells cultivatedin vitro to commence formation of antibodies. Cellular and Molecular Life Sciences. 15(2). 62–64. 4 indexed citations
19.
Šterzl, J., et al.. (1959). Attempts to transfer tuberculin hypersensitivity to young rabbits. Folia Microbiologica. 4(1). 60–61. 7 indexed citations
20.
Šterzl, J., et al.. (1958). A bactericidal serum substance unrelated to complement. 3(6). 348–363.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026